These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 19903320)

  • 21. Quality control technique to reduce the variability of longitudinal measurement of hemoglobin mass.
    Gough CE; Sharpe K; Ashenden MJ; Anson JM; Saunders PU; Garvican LA; Bonetti DL; Gore CJ; Prommer N
    Scand J Med Sci Sports; 2011 Dec; 21(6):e365-71. PubMed ID: 21535184
    [TBL] [Abstract][Full Text] [Related]  

  • 22. On the trail of blood doping-microRNA fingerprints to monitor autologous blood transfusions in vivo.
    Mussack V; Wittmann G; Pfaffl MW
    Am J Hematol; 2021 Mar; 96(3):338-353. PubMed ID: 33326140
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Monitoring of biological markers indicative of doping: the athlete biological passport.
    Saugy M; Lundby C; Robinson N
    Br J Sports Med; 2014 May; 48(10):827-32. PubMed ID: 24659506
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A third generation approach to detect erythropoietin abuse in athletes.
    Sharpe K; Ashenden MJ; Schumacher YO
    Haematologica; 2006 Mar; 91(3):356-63. PubMed ID: 16503554
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detection of EPO doping and blood doping: the haematological module of the Athlete Biological Passport.
    Schumacher YO; Saugy M; Pottgiesser T; Robinson N
    Drug Test Anal; 2012 Nov; 4(11):846-53. PubMed ID: 22374784
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Study of a new indirect method based on absolute norms of variation to detect autologous blood transfusion.
    Sallet P; Brunet-Guedj E; Mornex R; Baverel G
    Int J Hematol; 2008 Nov; 88(4):362-368. PubMed ID: 18946638
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Second-generation blood tests to detect erythropoietin abuse by athletes.
    Gore CJ; Parisotto R; Ashenden MJ; Stray-Gundersen J; Sharpe K; Hopkins W; Emslie KR; Howe C; Trout GJ; Kazlauskas R; Hahn AG
    Haematologica; 2003 Mar; 88(3):333-44. PubMed ID: 12651273
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detection of autologous blood transfusions using a novel dried blood spot method.
    Cox HD; Miller GD; Lai A; Cushman D; Eichner D
    Drug Test Anal; 2017 Nov; 9(11-12):1713-1720. PubMed ID: 29045074
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Desmopresssin and hemodilution: implications in doping.
    Sanchis-Gomar F; Martinez-Bello VE; Nascimento AL; Perez-Quilis C; Garcia-Gimenez JL; Viña J; Gomez-Cabrera MC
    Int J Sports Med; 2010 Jan; 31(1):5-9. PubMed ID: 19885778
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Altitude exposure in sports: the Athlete Biological Passport standpoint.
    Sanchis-Gomar F; Pareja-Galeano H; Brioche T; Martinez-Bello V; Lippi G
    Drug Test Anal; 2014 Mar; 6(3):190-3. PubMed ID: 24115763
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reticulocyte parameters as potential discriminators of recombinant human erythropoietin abuse in elite athletes.
    Parisotto R; Gore CJ; Hahn AG; Ashenden MJ; Olds TS; Martin DT; Pyne DB; Gawthorn K; Brugnara C
    Int J Sports Med; 2000 Oct; 21(7):471-9. PubMed ID: 11071048
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of physical fitness and endurance exercise on indirect biomarkers of recombinant erythropoietin misuse.
    Abellan R; Ventura R; Pichini S; Palmi I; Bellver M; Olive R; Pacifici R; Pascual JA; Zuccaro P; Segura J
    Int J Sports Med; 2007 Jan; 28(1):9-15. PubMed ID: 16804802
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [A comparison of autologous transfusion procedures in hip surgery].
    Lorentz A; Osswald PM; Schilling M; Jani L
    Anaesthesist; 1991 Apr; 40(4):205-13. PubMed ID: 2058822
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinical study of autologous blood transfusion in pregnant women].
    Kuromaki K; Takeda S; Seki H; Kinoshita K; Hitomi Y; Maeda H
    Nihon Sanka Fujinka Gakkai Zasshi; 1994 Nov; 46(11):1213-20. PubMed ID: 7844439
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Autologous Blood Transfusion in Sports: Emerging Biomarkers.
    Salamin O; De Angelis S; Tissot JD; Saugy M; Leuenberger N
    Transfus Med Rev; 2016 Jul; 30(3):109-15. PubMed ID: 27260108
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New drugs and methods of doping and manipulation.
    Thevis M; Kohler M; Schänzer W
    Drug Discov Today; 2008 Jan; 13(1-2):59-66. PubMed ID: 18190865
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepcidin as a new biomarker for detecting autologous blood transfusion.
    Leuenberger N; Barras L; Nicoli R; Robinson N; Baume N; Lion N; Barelli S; Tissot JD; Saugy M
    Am J Hematol; 2016 May; 91(5):467-72. PubMed ID: 26822428
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hematologic passport for athletes competing in endurance sports: a feasibility study.
    Malcovati L; Pascutto C; Cazzola M
    Haematologica; 2003 May; 88(5):570-81. PubMed ID: 12745277
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of reinfusion of autologous blood on exercise performance in cross-country skiers.
    Berglund B; Hemmingson P
    Int J Sports Med; 1987 Jun; 8(3):231-3. PubMed ID: 3623787
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel method utilising markers of altered erythropoiesis for the detection of recombinant human erythropoietin abuse in athletes.
    Parisotto R; Gore CJ; Emslie KR; Ashenden MJ; Brugnara C; Howe C; Martin DT; Trout GJ; Hahn AG
    Haematologica; 2000 Jun; 85(6):564-72. PubMed ID: 10870111
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.